Phase II Trial of Allogeneic Transplantation Plus Novel Drugs in Multiple Myeloma: Effect of Intensifying Reduced-Intensity Conditioning with Bortezomib and Adding Maintenance Treatment
- Reinoso-Segura, M.
- Caballero-Velázquez, T.
- Herrera, P.
- Patriarca, F.
- Fanin, R.
- Bruno, B.
- Einsele, H.
- Nahi, H.
- Granell, M.
- López-Corral, L.
- Reguera, J.L.
- García-Cadenas, I.
- Gahrton, G.
- Pérez-Simón, J.A.
ISSN: 2666-6367
Argitalpen urtea: 2022
Alea: 28
Zenbakia: 5
Orrialdeak: 258.e1-258.e8
Mota: Artikulua